Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia

Beijing 302 Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
relapsed acute myeloid leukemia, refractory acute myeloid leukemia, minimal residual disease, venetoclax, hypomethylation agent, cytarabine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1046436
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.